Subscribe to Newsletter

Small Molecules

Business & Regulation Business Practice

Adapting to Change

| Maryam Mahdi

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.
Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.
Discovery & Development Drug Discovery

The Gut Response

| Maryam Mahdi

In what ways can the microbiome interact with oral medicines?
Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Vine

Nominations are now open for The Medicine Maker 2021 Power List.

Manufacture Standards & Regulation

A Blossoming Market

| Maryam Mahdi

How is the Indian pharmaceutical industry adapting to meet new demands?
Manufacture Small Molecules

A Year of Challenge and Opportunity

| Maryam Mahdi

How do we manage the fallout caused by the COVID-19 pandemic?
Manufacture Technology and Equipment

The Trends Behind the Tech

| Maryam Mahdi

Richard Stedman from ACG Engineering outlines the trends driving change in the Indian pharmaceutical equipment industry.
Manufacture Technology and Equipment

Breaking With Tradition

| Mark Muldowney

Is continuous manufacturing worth the investment for pharma companies?
Business & Regulation Small Molecules

Sayonara, Serendipity

| James Strachan

How can small molecule "degraders" help target disease-causing proteins?
Manufacture Small Molecules

Mighty Morphin’ Small Molecules

| James Strachan

New method to control polymorphism could see “widespread use across the pharma industry”.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker